Frey, Dario L.
Helm, Barbara
Guerra, Matteo
Hagner, Matthias
Lu, Junyan
Dittrich, A. Susanne
Wege, Sabine
Eberhardt, Ralf
Herth, Felix J. F.
Sommerburg, Olaf
Schultz, Carsten
Dalpke, Alexander H.
Klingmüller, Ursula
Mall, Marcus A.
Boutin, Sébastien
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Article History
Received: 1 September 2025
Accepted: 10 December 2025
First Online: 24 December 2025
Declarations
:
: M.A.M. reports grants from the German Research Foundation, the German Innovation Fund, and Vertex Pharmaceuticals outside of the submitted work. Additionally, he reports receipt of consulting fees from Boehringer Ingelheim, Enterprise Therapeutics, Kither Biotec, Splisense, and Vertex Pharmaceuticals, of honoraria for lectures from Vertex Pharmaceuticals Incorporated and participation in advisory boards from Boehringer Ingelheim, Enterprise Therapeutics, Kither Biotec, Pari, Vertex Pharmaceuticals, and of payment for travel from Vertex Pharmaceuticals Incorporated and Boehringer Ingelheim, all outside of the submitted work. He is a Fellow of ERS (FERS). C.S. reports grants from the NIH (R01GM127631, R01AI141549) outside the submitted work. Additionally, he reports receipt of consulting fees from SiChem GmbH, Bremen. All other authors have nothing to disclose.